<DOC>
	<DOC>NCT02976051</DOC>
	<brief_summary>Aim: To improve curability of radiotherapy in HNSCC patients identified by hypoxic FAZA-PET scanning</brief_summary>
	<brief_title>DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC</brief_title>
	<detailed_description>Prospective phase II study aiming to improve the outcome in hypoxic resistent patients identified by FAZA-PET. Inclusion: Patients must fulfill the following: Positive hypoxic FAZA-PET Scanning (as described in DAHANCA 24 - see citation) Stage III-IV, Squamous cell carcinoma of the larynx, pharynx or oral cavity (HPVneg (oropharynx) Indication for hyperfractionated accelerated radiotherapy with concommitant cis-platin and nimorazole</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Stage IIIIV larynx, pharynx, oral cavity Hypoxic FAZAPET positive Indication for primary radiochemotherapy Informed consent HPV positive oropharynx cancer Primary surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>